First Turn Management, LLC
Source: SEC Form 13F · as of Mar 2026First Turn Management, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $580.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$580.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for Abivax SA (ABVX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ABVXAbivax SA | 465,869 | $51.9M |
| BBIOBridgeBio Pharma, Inc. | 695,718 | $51.7M |
| RVMDREVOLUTION MEDICINES, INC. | 468,376 | $45.5M |
| APGEApogee Therapeutics, Inc. | 513,770 | $43.2M |
| INSMINSMED Inc | 248,475 | $40.6M |
| NUVLNuvalent, Inc. | 370,344 | $37.9M |
| COGTCogent Biosciences, Inc. | 947,339 | $36.5M |
| ROIVRoivant Sciences Ltd. | 1,190,118 | $33.0M |
| AXSMAxsome Therapeutics, Inc. | 188,772 | $31.9M |
| ORICOric Pharmaceuticals, Inc. | 2,017,284 | $25.6M |
| ELVNEnliven Therapeutics, Inc. | 623,839 | $24.5M |
| SRRKScholar Rock Holding Corp | 446,390 | $21.9M |
| CYTKCYTOKINETICS INC | 283,700 | $18.7M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 220,921 | $18.5M |
| PVLAPALVELLA THERAPEUTICS, INC. | 148,093 | $18.5M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 558,336 | $17.9M |
| VRDNViridian Therapeutics, Inc.\DE | 911,337 | $17.8M |
| TERNTerns Pharmaceuticals, Inc. | 326,694 | $17.2M |
| OLMAOlema Pharmaceuticals, Inc. | 768,662 | $11.5M |
| QUREuniQure N.V. | 615,489 | $10.1M |
| MLTXMoonLake Immunotherapeutics | 315,563 | $5.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.